/Zimmer%20Biomet%20Holdings%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
Warsaw, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) designs, manufactures, and markets effective, innovative solutions that support orthopedic surgeons and clinicians in restoring mobility, alleviating pain, and improving the quality of life for patients worldwide. With a market cap of $18.6 billion, it operates in more than 25 countries across the globe and sells products in more than 100 countries.
Zimmer is expected to release its Q2 earnings before the markets open on Thursday, Aug. 7. Ahead of the event, analysts expect it to report a profit of $1.99 per share, down 1% from $2.01 per share reported in the year-ago quarter. While the company has missed the Street’s bottom-line estimates once over the past four quarters, it has surpassed the estimates on three other occasions.
